Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)
This NIH U54 cooperative agreement funds establishment of a Center that trains researchers in product development for new substance use disorder (SUD) pharmacotherapeutics and advances promising co…
- Deadline
- Sep 30, 2026
- Posted
- May 21, 2026
- Award amount
- Amount not specified
- Focus areas
- Health
In plain English
This NIH U54 cooperative agreement funds establishment of a Center that trains researchers in product development for new substance use disorder (SUD) pharmacotherapeutics and advances promising concepts with technical and financial support. Unusually for NIH, foreign organizations and foreign components are eligible to apply under this opportunity. Clinical trials are not allowed under this mechanism. No specific award amount is stated; refer to the NOFO for full eligibility details.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Who can apply
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
About this grant
The purpose of this notice of funding opportunity (NOFO) is to establish a Center that trains researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics and to advance the best concepts through initial experiments via technical and financial support.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants funding Health — soonest deadline first.
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
National Institutes of Health · Amount varies · Closed
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health · Up to $1M · Due in 3 days
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health · Amount varies · Due in 5 days
Advancing Research on Empirically-Supported Interventions for Older Adults Living with Serious Mental Illness (SMI) (R01 Clinical Trial Optional)
National Institutes of Health · Amount varies · Due in 9 days
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
National Institutes of Health · Up to $300K · Due in 10 days
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
National Institutes of Health · Amount varies · Due Dec 4, 2026
Also listed under National Institutes of Health and Health Grants.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.